首页> 外文期刊>The Journal of Urology >Long-term outcome of simultaneous transurethral resection of bladder tumor and prostate in patients with nonmuscle invasive bladder tumor and bladder outlet obstruction.
【24h】

Long-term outcome of simultaneous transurethral resection of bladder tumor and prostate in patients with nonmuscle invasive bladder tumor and bladder outlet obstruction.

机译:非肌肉浸润性膀胱肿瘤和膀胱出口梗阻患者同时经尿道膀胱肿瘤和前列腺切除术的长期结果。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: We evaluated the long-term outcome of simultaneous transurethral bladder tumor and prostate resection in patients with nonmuscle invasive bladder tumor and bladder outlet obstruction. MATERIALS AND METHODS: Between April 1997 and April 2006, 213 patients with nonmuscle invasive bladder tumor who had a minimum followup of 24 months were included in the study, including group 1-107 with transurethral resection of bladder tumor only and group 2-106 with transurethral bladder tumor and prostate resection. Simultaneous transurethral bladder tumor and prostate resection was performed at surgeon discretion. The records were retrospectively analyzed for clinicopathological parameters, recurrence and progression rates, time to recurrence and postoperative uroflowmetry results in the 2 groups. RESULTS: There were no significant differences in clinicopathological parameters between the 2 groups. At a mean followup of 54.3 and 50.1 months in groups 1 and 2, respectively, group 2 patients with a tumor lessthan 3 cm or a single tumor had a significantly lower recurrence rate than group 1 patients. None of the 31 patients with recurrence in group 2 had recurrence in the bladder neck or prostatic urethra where transurethral prostate resection had been done. There was no significant difference in the progression rate between the 2 groups. The 60-month recurrence-free probability in groups 1 and 2 was 43.4% and 52.0%, respectively. Three months after surgery the postvoid residual urine volume had significantly decreased in group 2. CONCLUSIONS: Simultaneous transurethral bladder tumor and prostate resection may help decrease bladder cancer recurrence and delay time to recurrence without the risk of cancer implantation when transurethral prostate resection is done, especially in patients with a papillary, solitary-appearing bladder lesion less than 3 cm.
机译:目的:我们评估了非肌肉浸润性膀胱肿瘤和膀胱出口梗阻患者同时经尿道膀胱肿瘤和前列腺切除术的长期结果。材料与方法:在1997年4月至2006年4月之间,本研究纳入了至少随访24个月的213例非肌肉浸润性膀胱肿瘤患者,其中包括1-107组仅行经尿道膀胱肿瘤切除术的患者和2-106例患者。经尿道膀胱肿瘤和前列腺切除术。外科医生酌情同时行经尿道膀胱肿瘤和前列腺切除术。回顾性分析两组患者的临床病理参数,复发和进展率,复发时间和术后尿流测定结果。结果:两组之间的临床病理参数没有显着差异。在第1组和第2组分别平均54.3和50.1个月的随访中,第2组肿瘤小于3 cm或单个肿瘤的复发率明显低于第1组患者。第2组的31例复发患者中,经经尿道前列腺切除术的膀胱颈或前列腺尿道均无复发。两组之间的进展率没有显着差异。第一组和第二组的60个月无复发机率分别为43.4%和52.0%。手术后三个月,第2组的术后残余尿量显着减少。结论:经尿道前列腺前列腺癌切除术同时行经尿道膀胱肿瘤切除术和前列腺切除术可能有助于减少膀胱癌的复发并延迟复发时间,而无癌症植入的危险。乳头状,单发性膀胱病变小于3厘米的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号